Ferric citrate for the treatment of hyperphosphatemia and iron deficiency anaemia in patients with NDD-CKD: a systematic review and meta-analysis

• Ngā kaituhi matua: Xueying Ding (Author), Shujie Sun (Author), Jinjin Zhang (Author), Huifang Zhao (Author), Fenglan Lun (Author), Xuemin Liu (Author), Yiwan Zhen (Author), Jinping Dong (Author), Jingliang Wu (Author)
• Hōputu: Pukapuka
• I whakaputaina: Frontiers Media S.A., 2024-03-01T00:00:00Z.
• Ngā marau: article
• Urunga tuihono: Connect to this object online.

Background: The application of ferric citrate therapy has yielded unexpected benefits in recent years for Chronic kidney disease patients suffering from hyperphosphatemia and iron deficiency -anaemia. Despite this, earlier research on the impact of ferric citrate on NDD-CKD has been contentious.Obje...